Published in Biotech Business Week, November 7th, 2005
The hallmark of the system is the nanotechnology-based approach to sequencing invented by the U.S.-based 454 Life Sciences.
Roche Diagnostics will offer the Genome Sequencer 20 System and reagents, and 454 Life Sciences will continue to manufacture instrument systems and reagent kits for Roche Diagnostics, with the option to transfer the responsibility for reagent manufacturing to Roche Diagnostics given sufficient sales...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.